ATE250673T1 - Verfahren zur identifizierung metastatischer sequenzen - Google Patents

Verfahren zur identifizierung metastatischer sequenzen

Info

Publication number
ATE250673T1
ATE250673T1 AT96942779T AT96942779T ATE250673T1 AT E250673 T1 ATE250673 T1 AT E250673T1 AT 96942779 T AT96942779 T AT 96942779T AT 96942779 T AT96942779 T AT 96942779T AT E250673 T1 ATE250673 T1 AT E250673T1
Authority
AT
Austria
Prior art keywords
sequences
cells
metastatic
probes
cell line
Prior art date
Application number
AT96942779T
Other languages
English (en)
Inventor
Timothy Thompson
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/594,031 external-priority patent/US5783182A/en
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE250673T1 publication Critical patent/ATE250673T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96942779T 1995-11-16 1996-11-15 Verfahren zur identifizierung metastatischer sequenzen ATE250673T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US683895P 1995-11-16 1995-11-16
US08/594,031 US5783182A (en) 1996-01-30 1996-01-30 Method for identifying metastatic sequences
PCT/US1996/018567 WO1997018454A2 (en) 1995-11-16 1996-11-15 Method for identifying metastatic sequences

Publications (1)

Publication Number Publication Date
ATE250673T1 true ATE250673T1 (de) 2003-10-15

Family

ID=26676129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96942779T ATE250673T1 (de) 1995-11-16 1996-11-15 Verfahren zur identifizierung metastatischer sequenzen

Country Status (6)

Country Link
EP (1) EP0870057B1 (de)
AT (1) ATE250673T1 (de)
AU (1) AU725186B2 (de)
CA (1) CA2237929A1 (de)
DE (1) DE69630142D1 (de)
WO (1) WO1997018454A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6172211B1 (en) 1997-07-11 2001-01-09 Boehringer Ingelheim International Gmbh Nucleic acid encoding tag7 polypeptide
US6277571B1 (en) 1997-10-03 2001-08-21 Virginia Commonwealth University Intellectual Property Foundation Sequential consensus region-directed amplification of known and novel members of gene families
CA2308565A1 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
US6545139B1 (en) 1998-03-13 2003-04-08 Baylor College Of Medicine DNA sequence encoding the p99 gene and kits for the detection of neoplasia
AU6531101A (en) 2000-06-02 2001-12-17 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1188839A1 (de) * 2000-09-19 2002-03-20 EVOTEC Neurosciences GmbH Verwendung von "Caveolae-Associated Integral " Membranprotein zur Diagnose und in Therapie von Alzheimer und verbundenen Neurodegenerativen Erkrankungen
EP1385993B8 (de) 2000-12-08 2011-09-21 Celldex Therapeutics, Inc. Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen
US7157558B2 (en) 2001-06-01 2007-01-02 Genentech, Inc. Polypeptide encoded by a polynucleotide overexpresses in tumors
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin
WO2004002516A1 (ja) * 2002-06-28 2004-01-08 Takeda Chemical Industries, Ltd. 呼吸器疾患の診断・予防・治療剤
US20090197249A1 (en) 2004-11-01 2009-08-06 George Mason University Compositions and methods for diagnosing colon disorders
JP2010514692A (ja) 2006-12-20 2010-05-06 バイエル ヘルスケア リミティド ライアビリティ カンパニー 癌の治療に有用なヒドロキシメチルフェニルピラゾリル尿素化合物
CN103079567A (zh) 2010-04-17 2013-05-01 拜尔健康护理有限责任公司 用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物
EP2673363B1 (de) 2011-02-11 2017-08-23 The Rockefeller University Behandlung von angiogenesebeschwerden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1181234B (it) * 1984-11-22 1987-09-23 Giovanni Zago Sistemi di pulizia automatica per videoregistratori e cassette di pulizia cosi' realizzate
FI863095A0 (fi) * 1984-11-30 1986-07-29 Whitehead Biomedical Inst Transmissibla daeggdjursgener associerade med tumoermetastaser.
GB9311130D0 (en) * 1993-05-28 1993-07-14 Isis Innovation Tumor metastasis gene
WO1995019369A1 (en) * 1994-01-14 1995-07-20 Vanderbilt University Method for detection and treatment of breast cancer
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
CA2237929A1 (en) 1997-05-22
EP0870057B1 (de) 2003-09-24
EP0870057A2 (de) 1998-10-14
DE69630142D1 (de) 2003-10-30
WO1997018454A3 (en) 1997-08-14
AU1160997A (en) 1997-06-05
WO1997018454A2 (en) 1997-05-22
AU725186B2 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
DE69630142D1 (de) Verfahren zur identifizierung metastatischer sequenzen
DE69823347D1 (de) Mikrofluidisches system und verfahren zu dessen betrieb
NO20022945D0 (no) Fremgangsmåte for isolering av RNA fra formalin-fikserte paraffin-innstöpte vevspröver
DE60120151D1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
DE69824004D1 (de) Verfahren zur quantitativen bestimmung der genexpression mit hilfe der multiplexen competitiven reversen-transkriptase polymerase kettenreaktion
ATE121794T1 (de) Verfahren zum nachweis des karzinogenen menschlichen papillomavirus.
TR199901667T2 (xx) 3-Heterosiklil-ikame edilmi� benzoil t�revleri
DK0979308T3 (da) Fremgangsåde til fremstilling af et diagnostisk standard gen-transkriptmönster
ATE224736T1 (de) Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie
DE60029369D1 (de) Verfahren und Sondenset zur Erkennung von Krebs
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE69918089D1 (de) Btk inhibitoren und verfahren zur identifizierung und verwendung
NO20002980D0 (no) Universelt celleoppsamlingsmedium
ATE182180T1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE60333295D1 (de) Verfahren zum nachweis abnormal methylierter nukleinsäure in heterogenen biologischen proben
ATE365227T1 (de) Endometriose marker und verwendung derselben
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
ATE329057T1 (de) Prostata-spezifische gene zur diagnose, prognose und behandlung von prostata-krebs
DE60326748D1 (de) Verfahren zur identifizierung des brustkrebsrisikos
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
ATE369360T1 (de) Heterocyclische verbindungen und deren verwendung in der detektion von nucleinsäuren
DE60043775D1 (de) Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern
DE69823372T8 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
EP0128018A3 (en) Molecular genetic probe, and method of forming same, assay technique and kit using said molecular genetic probe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties